Your browser doesn't support javascript.
loading
Increasing Appropriate BRCA1/2 Mutation Testing: The Role of Family History Documentation and Genetic Counseling in a Multidisciplinary Clinic.
Kishan, Amar U; Gomez, Caitlin L; Dawson, Nicole A; Dvorak, Robyn; Foster, Nova M; Hoyt, Anne; Hurvitz, Sara A; Kusske, Amy; Silver, Erica L; Tseng, Charles; McCloskey, Susan A.
Afiliación
  • Kishan AU; Department of Radiation Oncology, University of California, Los Angeles, CA, USA. aukishan@mednet.ucla.edu.
  • Gomez CL; Department of Radiation Oncology, University of California, Los Angeles, CA, USA.
  • Dawson NA; Department of Pathology and Laboratory Medicine, University of California, Los Angeles, CA, USA.
  • Dvorak R; Santa Monica-UCLA Breast Center, University of California, Los Angeles, CA, USA.
  • Foster NM; Department of Surgery, Division of General Surgery, University of California, Los Angeles, CA, USA.
  • Hoyt A; Department of Radiology, University of California, Los Angeles, CA, USA.
  • Hurvitz SA; Department of Hematology and Oncology, University of California, Los Angeles, CA, USA.
  • Kusske A; Department of Surgery, Division of General Surgery, University of California, Los Angeles, CA, USA.
  • Silver EL; Santa Monica-UCLA Breast Center, University of California, Los Angeles, CA, USA.
  • Tseng C; Department of Plastic Surgery, University of California, Los Angeles, CA, USA.
  • McCloskey SA; Department of Radiation Oncology, University of California, Los Angeles, CA, USA.
Ann Surg Oncol ; 23(Suppl 5): 634-641, 2016 12.
Article en En | MEDLINE | ID: mdl-27619940
ABSTRACT

BACKGROUND:

Findings show that 5-10 % of women with a diagnosis of breast cancer (BCa) have actionable genetic mutations. The National Comprehensive Cancer Network guidelines for testing to detect BRCA1/2 mutations include personal history (PH) variables such as age of 45 years or younger and a family history (FH) variables. Rates of FH documentation and overall rates of appropriate referral for genetic testing are low, ranging from about 30 to 60 %. The authors hypothesized that an upfront FH documentation and inclusion of a genetics counselor in a multidisciplinary clinic (MDC) setting would increase rates of appropriate referral for genetic testing.

METHODS:

The study enrolled 609 consecutive women with non-metastatic BCa seen in consultation between June 2012 and December 2015 at a multidisciplinary clinic. Rates of FH documentation and referral for genetic testing to detect BRCA1/2 mutations were assessed before and after inclusion of a genetic counselor in the MDC.

RESULTS:

The rates of FH documentation and appropriate referral were 100 and 89 %, respectively. Half (50 %) of the patients had only FH-based indications for testing. All the patients with PH-based indications were referred. The inclusion of a genetic counselor significantly increased appropriate referral rates among those with only FH-based indications (62 vs. 92 %) and overall (80 vs. 96 %) (p < 0.0001 for both). Among the 12 % of the patients with actionable mutations, 60 % were 45 years of age or younger, whereas 30 % had only FH-based testing indications.

CONCLUSIONS:

This report shows substantially higher FH documentation and appropriate genetic testing rates than prior reports. Many patients with indications for genetic testing may have only FH-based indications for testing, and this subset may account for the sizable proportion of patients with newly diagnosed BCa who have actionable mutations.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Grupo de Atención al Paciente / Derivación y Consulta / Neoplasias de la Mama / Pruebas Genéticas / Asesoramiento Genético / Anamnesis Tipo de estudio: Guideline / Prognostic_studies Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: Ann Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 2_ODS3 Problema de salud: 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Grupo de Atención al Paciente / Derivación y Consulta / Neoplasias de la Mama / Pruebas Genéticas / Asesoramiento Genético / Anamnesis Tipo de estudio: Guideline / Prognostic_studies Límite: Adult / Female / Humans / Middle aged Idioma: En Revista: Ann Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos
...